The short version
WHO guidance recommends adults do muscle-strengthening activity on two or more days a week, alongside aerobic activity. A meta-analysis of 16 prospective cohort studies found that any muscle-strengthening activity was associated with roughly 10-17% lower all-cause mortality and lower risk of several non-communicable diseases, with the lowest risk around 30-60 minutes a week and a J-shaped curve at higher volumes. These are cohort associations, not trials, so they describe people who strength-train rather than proving the training caused the difference.
Why two days
WHO's 2020 guidance sets muscle strengthening at two or more days a week for adults, alongside 150-300 minutes of moderate aerobic activity. It is a population recommendation built from systematic evidence reviews, not a personalised prescription.
Two days is also a practical minimum: it gives each muscle group a stimulus with recovery in between, and it survives a bad week better than a four-day split.
[C01]
What the cohort data show
A meta-analysis of 16 prospective cohort studies found muscle-strengthening activity associated with lower all-cause mortality and lower risk of several major non-communicable diseases, independent of aerobic activity in the pooled models.
The dose-response was J-shaped: the lowest risk was around 30-60 minutes a week, with associations weakening or reversing at much higher volumes.
[C02]
The honest caveat
Every study in that meta-analysis was observational. People who strength-train tend to differ from those who do not in smoking, diet, income, baseline health and medical access. Adjustment reduces but does not remove that.
So the correct statement is not 'lifting twice a week extends your life by X years'. It is that the association is consistent, the behaviour is low-risk for most people, and it is recommended by a recognised body.
[C02]
What a minimal session looks like
The guideline does not specify exercises. A workable minimum covers the main movement patterns: a squat or lunge, a push, a pull, and a hinge, each taken close to the point where the last repetition is hard.
Starting lighter than feels necessary is normal. The first two weeks are about learning the movement, not about load.
[C01] [C02]
Claims, sources and what they can carry
Every claim links to the source(s) behind it. Weights rank source types
(Cochrane/systematic reviews 1.0, recognised guidelines 0.9, RCTs 0.8, observational or
preprint 0.5, mechanistic 0.2). A weight is not certainty and is not GRADE.
establishedc-01WHO recommends adults do muscle-strengthening activity on two or more days a week, in addition to aerobic activity.
Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451-1462.
PMID 33239350WHO guideline (Guideline Development Group with systematic evidence reviews). · weight 0.9 · Adults: 150-300 min/week moderate (or 75-150 min vigorous) aerobic activity, plus muscle-strengthening on 2 or more days/week, and reduction of sedentary time. Some activity is better than none.↑ back to the article
directionalc-02Any muscle-strengthening activity was associated with roughly 10-17% lower all-cause mortality across 16 cohort studies, with the lowest risk around 30-60 minutes a week and a J-shaped curve above that.
Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. Br J Sports Med. 2022;56(13):755-763.
PMID 35228201Systematic review and meta-analysis of 16 prospective cohort studies (PROSPERO CRD42020219808). · weight 1.0 · Any muscle-strengthening activity was associated with roughly 10-17% lower all-cause mortality and lower risk of several non-communicable diseases; the lowest risk was around 30-60 min/week, with a J-shaped curve at higher volumes.↑ back to the article
Evidence ledger for this entry
| Source | Type | Weight | PubMed |
| src-who-pa | guideline recognized body | 0.9 | 33239350 |
| src-rt-01 | systematic review meta analysis | 1.0 | 35228201 |
Verification in this run was record/abstract level via NCBI E-utilities. Full text
was not read and no retraction database was queried. Sources with a recorded verification gap are
flagged in place.